AVE0991通过HOTAIRM1/miR223-3p/α-突触核蛋白轴改善帕金森病中的多巴胺能神经元损伤

AVE0991 ameliorates dopaminergic neuronal damage in Parkinson’s disease through HOTAIRM1/miR223-3p/α-synuclein axis

ES评分 0

DOI 10.1038/s41598-024-76058-w
刊名
年,卷(期) 2024, 14(1)
作者
作者单位 Department of Neurology, Nanjing First Hospital, Nanjing Medical University;
Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University;
School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University

摘要
帕金森病(PD)是一种常见的神经退行性疾病。AVE0991是Ang-(1–7)的非肽类似物,已被发现可改善PD的进展,但AVE0991调控PD进展的具体机制仍不清楚。本研究建立过表达人α-突触核蛋白(hα-syn,A53T)的小鼠以模拟PD病理,并在体外构建过表达hα-syn(A53T)的小鼠多巴胺能神经元模型。采用[18F]FDG-PET/CT方法评估过表达人α-syn(A53T)小鼠的FDG摄取。通过qRT-PCR检测lncRNA HOTAIRM1和miR-223-3p水平。采用流式细胞术检测细胞凋亡。研究发现,AVE0991改善了帕金森病小鼠的行为障碍,并降低了其黑质中α-syn表达。AVE0991通过lncRNA HOTAIRM1抑制过表达hα-syn(A53T)的多巴胺能神经元凋亡。MiR-223-3p作为ceRNA与HOTAIRM1结合,并直接靶向α-syn。此外,发现外周血中miR-223-3p水平与α-syn呈负相关。本研究提示,Ang-(1–7)类似物AVE0991靶向HOTAIRM1/miR-223-3p轴以降解PD小鼠中的α-突触核蛋白,并在体外表现出神经保护作用。
Abstract
Parkinson’s disease (PD) is a prevalent type of neurodegenerative disorder. AVE0991, a non-peptide analogue of Ang-(1–7), by which the progression of PD has been discovered to be ameliorated, but the specific mechanism whereby AVE0991 modulates the progression of PD re-mains unclear. The mice overexpressing human α-syn (A53T) were established to simulate PD pathology, and we also constructed an in vitro model of mouse dopaminergic neurons overexpressing hα-syn (A53T). The [18F] FDG-PET/CT method was employed to assess FDG uptake in human α-syn (A53T) overexpressing mice. Levels of lnc HOTAIRM1 and miR-223-3p were detected via qRT-PCR. Flow cytometry was deployed to assay cell apoptosis. Here, we found that AVE0991 improved behaviour disorders and decreased α-syn expression in the substantia nigra of mice with Parkinson’s disease. AVE0991 inhibited the apoptosis of dopaminergic neurons overexpressing hα-syn (A53T) via lncRNA HOTAIRM1. MiR-223-3p binds to HOTAIRM1 as a ceRNA and directly targets α-syn. Moreover, miR-223-3p level in peripheral blood was found negatively correlated with the α-syn. Our present study shows that the angiotensin-(1–7) analogue AVE0991 targeted at the HOTAIRM1/miR-223-3p axis to degrade α-synuclein in PD mice, and showed neuroprotection in vitro.
关键词
帕金森病;AVE0991;α-突触核蛋白(α-syn);HOTAIRM1(长链非编码RNA);miR-223-3p(微小RNA-223-3p)。
KeyWord
Parkinson’s disease, AVE0991, α-syn, HOTAIRM1, miR-223-3p
基金项目
页码 26346-/
  • 参考文献
  • 相关文献
  • 引用本文

RuiDuan,LiangShi,YangDeng,JiangWu,ShiyaoWang,QiangPeng,ZhongyuanLi,ZhaohanXu,FengWang,XueXue,QingGao. AVE0991通过HOTAIRM1/miR223-3p/α-突触核蛋白轴改善帕金森病中的多巴胺能神经元损伤 [J]. Scientific Reports. 2024; 14; (1). 26346 - /.

  • 文献评论

相关学者

相关机构